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Identification of ethyl pyruvate as a NLRP3
inflammasome inhibitor that preserves
mitochondrial integrity
Sujun Li1†, Fang Liang1†, Kevin Kwan2†, Yiting Tang3,4, Xiangyu Wang1,4, Youzhou Tang1, Jianhua Li2, Huan Yang2,
Sangeeta S. Chavan2, Haichao Wang5, Ulf Andersson6, Ben Lu1,4* and Kevin J. Tracey2*

Abstract
Background: The NLRP3 inflammasome, a cytosolic complex that mediates the maturation of IL-1β and IL-18 as well
as the release of high mobility group box 1 (HMGB1), contributes to the lethality of endotoxic shock. Ethyl
pyruvate (EP) was previously shown to inhibit HMGB1 release and promote survival during endotoxemia and
experimental sepsis. However, the underlying protective mechanism remains elusive.
Result: EP dose-dependently inhibited the ATP-, nigericin-, alum-, and silica-induced caspase-1 activation and HMGB1
release in mouse macrophages. EP failed to inhibit DNA transfection- or Salmonella Typhimurium-induced caspase-1
activation and HMGB1 release. Mechanistically, EP significantly attenuated mitochondrial damage and cytoplasmic
translocation of mitochondrial DNA, a known NLRP3 ligand, without influencing the potassium efflux, the lysosomal
rupture or the production of mitochondrial reactive oxygen species (mtROS).
Conclusion: Ethyl pyruvate acts as a novel NLRP3 inflammasome inhibitor that preserves the integrity of mitochondria
during inflammation.
Keywords: Ethyl pyruvate, The NLRP3 inflammasomes, Mitochondrial damage, HMGB1, Interleukin-1beta

Background
Macrophages, the cells at the front line of defense against
infection, express pattern-recognition receptors (PRRs) to
detect various inflammatory motifs. PRRs include the
membrane-bound Toll-like receptors (TLRs) and NOD-like
receptors (NLRs), which scan foreign invaders or sterile
tissue damages for pathogen-associated (PAMPs) or
damage-associated (DAMPs) molecular patterns. Many
NLR family member have been reported to exhibit inflammasome activity in vitro. For instance, NLR family, pyrin
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domain containing 3 (NLRP3) acts as danger sentinel that
self-oligomerize via homotypic NACHT domain interactions
to form high-molecular weight complexes that trigger
caspase-1 autoactivation (Schroder & Tschopp, 2010).
The NLRP3 inflammasome, an intracellular protein
complex consisting of NLRP3, ASC and Caspase-1, controls the activation of caspase-1 and the maturation of
the pro-inflammatory cytokines interleukin (IL)-1β and
IL-18 (Mariathasan et al., 2006). Accumulated evidence
show that the NLRP3 inflammasome also mediates the
release of high mobility group box 1 (HMGB1), a late
mediator of lethal sepsis, and contributes to the pathogenesis of septic shock (Lu et al., 2012; Lamkanfi et al.,
2010; Qin et al., 2006; Rittirsch et al., 2008; Wang et al.,
2004; Wang et al., 1999). HMGB1 is an evolutionarily
conserved and abundantly expressed nuclear and cytoplasmic protein. Under the physiological condition,
HMGB1 predominantly locates in the nucleus due to its
two nuclear location sequences (NLSs) in most cell types
(Lu et al., 2012; Andersson & Tracey, 2011). Infectious
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agents or molecules released from damaged cells, such
as lipopolysaccharide (LPS), a major cell wall component
of gram negative bacteria, ATP or monosodium uric acid
crystal (MSU) could induce the translocation of HMGB1
from the nucleus to the cytoplasm and the subsequent
release of HMGB1 (Lu et al., 2012; Andersson & Tracey,
2011). Extracellular HMGB1 exerts a variety of biological function by engaging multiple receptors. Though
the released HMGB1 might facilitate tissue repair during
sterile injury, excessive accumulation of extracellular
HMGB1 in tissue or circulation contributes importantly
to the pathogenesis of many inflammatory or autoimmune diseases, such as sepsis and colitis (Andersson
& Tracey, 2011). Notably, genetic deletion of NLRP3 or
ASC, two essential components of the NLRP3 inflammasome, blocked LPS-, ATP- or MSU-induced HMGB1 release in cultured macrophages or during endotoxemia
(Lamkanfi et al., 2010). Accordingly, the deletion of
NLRP3 or ASC confers significant protection against lethal endotoxemia (Mariathasan et al., 2006; Mariathasan
et al., 2004). Neutralizing the extracellular HMGB1 using
anti-HMGB1 monoclonal antibodies significantly increased the survival during lethal endotoxemia or bacterial sepsis (Lamkanfi et al., 2010; Qin et al., 2006;
Wang et al., 1999). These findings establish a critical role
of the NLRP3 inflammasome - HMGB1 axis in endotoxemia and sepsis.
We and others previously found that ethyl pyruvate, a
metabolite derivative, confers significant protection
against experimental sepsis- and endotoxemia-induced
lethality, and markedly attenuates the disease severity of
experimental colitis (Ulloa et al., 2002; Miyaji et al.,
2003; Davé et al., 2009). These studies also show that
ethyl pyruvate inhibits LPS-induced HMGB1 release
from cultured macrophages and during endotoxemia
(Ulloa et al., 2002). However, the underlying mechanism
by which ethyl pyruvate inhibits HMGB1 release remains unclear. Early works have shown that EP could
work as an anti-inflammatory agent. (Yang et al., 2016)
Besides, We and others previously show that inflammasome activation could trigger HMGB1 release in vitro
and in vivo (Lu et al., 2012; Lamkanfi et al., 2010). Considering pathogenic known role of the NLRP3 inflammasome in endotoxic shock (Mariathasan et al., 2006;
Mariathasan et al., 2004), together with EP’s antiinflammatory effect, here we postulate that ethyl pyruvate might inhibit HMGB1 release and thus play a
protective role in sepsis- and endotoxemia-induced lethality by inhibiting the NLRP3 inflammasome activation.

Methods
Reagents

Ultra-pure LPS and the NLRP3 inflammasome agonists ATP, Nigericin,Nano-SiO2, Alum Crystals were
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obtained from Invivogen (San Diego, California). Ethyl
pyruvate (EP) was purchased from ThermoFisher
Scientific(Shanghai, China). Anti-mouse IL-1β (AF-401NA) was from R&D and anti-mouse caspase-1 (sc-514)
was from Santa Cruz. Mouse HMGB1 mAb IgG2b 2G7
(noncommercial antibody), originally from Critical Therapeutic Inc. (Boston, MA, USA) is available upon request.
Acridine orange was purchased from SigmaAldrich (St.
Louis, MO). MitoSox™ was purchased from ThermoFisher
Scientific (Shanghai, China), and JC-1 from Beyotime
(C2006). Mitochondrial isolation and purification kits
were from QIAGEN (Hilden, Germany). Murine macrophage colony-stimulating factor (GM-CSF) and human
macrophage colony-stimulating factor (M-CSF) were
purchased from PEPROTECH (New Jersey, USA).

Cell preparation and stimulation
Peritoneal mouse macrophages

Peritoneal mouse macrophages C57BL/6 mice were
isolated in 10% sucrose solution following bilateral injection of 1 ml of thioglycolate bilaterally 3 days
prior. Cells were cultured in RPMI medium 1640 supplemented with 10% FBS, 100 U/mL penicillin, and
100 μg/mL streptomycin. One million peritoneal macrophages, plated in 12-well plates, were primed with
ultra-pure LPS (1 μg/ml) for 3 h in the presence or
the absence of EP (1 and 5 mM), and then stimulated
with ATP(5 mM, 30 min), Nigericin (10 μM,1 h),
Nano-SiO2 (10μg/ml, 6h) or Alum Crystals (20μg/ml,
6h). For Salmonella infection, wild-type S. typhimurium was grown overnight in Luria–Bertani (LB) broth,
then reinoculated at a dilution of 1:100 and grown to
mid-exponential phase (3 h) to induce expression of
the Salmonella pathogenicity island 1 type III secretion system. To minimize the involvement of NLRP3
inflammasome activation during Salmonella infection,
unprimed macrophages were infected with wild-type
S. typhimurium (m.o.i. is from 5 to 100). The supernatant samples were collected 1 h after infection. To
study AIM2 inflammasome activation, macrophages
were transfected with random DNA using Lipofectamine 2000 at a concentration of 1 mg DNA plus
3.5 ml lipofectamine 2000 per ml. The supernatant
samples were collected 6 h after transfection.

Human macrophages

Primary blood mononuclear cells were isolated by
density-gradient centrifugation. Then cells were collected and cultured in RPMI 1640 medium with 10%
heat-inactivated human serum. After 2 h incubation at
37 °C, Adherent cells were detached with 10 mM EDTA,
and then re-suspended (106 cells/ml) in medium
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supplemented with human macrophage colonystimulating factor (20 ng/ml), and cultured for 7 d.
Human acute monocytic leukemia cell lines (THP-1)

Human acute monocytic leukemia cell lines (THP1)were cultured in RPMI medium 1640 supplemented
with 10% FBS, 100 U/mL penicillin, and 100 μg/mL
streptomycin. When cells were 70% confluence, treatment was carried out in RPMI medium 1640.
Cytotoxicity assay

Cell supernatants were analyzed using a lactate dehydrogenase (LDH) cytotoxicity assay kit purchased from TAKARA
(California, USA) per manufacture recommendations.
Elisa

Levels of IL-1β, and TNF-α in the culture medium were
determined using quantitative ELISA kits (R & D Systems,
Minneapolis, MN, USA) and HMGB1 (IBL International)
according to the manufacturer’s instructions.
Western-blot analysis

Supernatant and cell lysates were analyzed using western
blot for caspase-1 p10, IL-1β, and HMGB1 release. Proteins from cell-free supernatants were extracted by methanol/chloroform precipitation as previously described.
Briefly, cell culture supernatants were precipitated by the
addition of an equal volume of methanol and 0.25 volumes of chloroform, then were vortexed and centrifuged
for 10 min at 20,000 g. The upper phase was discarded
and 500 μl methanol was added to the interphase. This
mixture was centrifuged for 10 min at 20,000 g and the
protein pellet was dried at 55 °C, re-suspended in
Laemmli buffer and boiled for 5 min at 99 °C. Cell extracts
were prepared as described previously (Wang et al., 2004).
Samples were separated by 4–20% SDS-PAGE or 4–20%
native-PAGE and were transferred onto PVDF membranes. The relative band intensity was quantified by using
the NIH image 1.59 software to determine HMGB1 levels
regarding standard curves generated with purified
HMGB1 as described previously.
Intracellular K+ concentration detection

Cells were washed twice with 0.9% Nacl and collected
after appropriate treatments. Then, 1 × 106 cells from
each group were resuspended in 300ul ddH2O. Then
the cells were subjected to there Freeze/thaw cycles.
Supernatant were collected and used for potassium
measurement. Potassium in these samples are assessed
by a automatic biochemical analyser (ABBOTT ARCHITECT C16000).
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Flow cytometry analysis

Mitochondrial ROS production, lysosomal rupture and
mitochondrial membrane potential were assessed by
flow cytometry. Briefly, to measure Mitochondrial ROS
production, cells were primed with ultra-pure LPS
(1 μg/ml) for 3 h in the presence of EP (5 mM), followed
by treatment with ATP (5 mM,30 min) or Nigericin
(10 μM,1 h). Staining treated cells with MitoSOX™
(2.5 μM) for 15 min at 37 °C. For lysosomal rupture
measuring, Peritoneal mouse macrophageswere primed
with ultra-pure LPS (1 μg/ml) for 3 h in the presence of EP
(5 mM), and then stained with Acridine Orange (1μg/ml)
for 30 min.After staining, stimulated cells with Alum
(20μg/ml) or Nano-SiO2(10μg/ml) 6 h. After treatment,
cells were collected and quickly transferred on ice for FACS
analysis. To determine mitochondrial potential-dependent
damage, cells were stained with JC-1 according to the manufacturer’s protocol. Cells were then monitored and analyzed by a flow cytometer (FACS Verse, BD Biosciences).
Mitochondrial DNA release assay

1 × 107 peritoneal macrophages were homogenized with
a TB syringe, and then were subjected to centrifugation
at 2000 g for 10 min at 4 °C. Protein concentration and
volume of the supernatant were normalized, followed by
centrifugation at 6000 g for 10 min at 4 °C to produce a
supernatant corresponding to the cytosolic fraction.
DNA was isolated from 200 μl of the cytosolic fraction
using a QIAamp DNA Minikit purchased from QIAGEN
(Hilden, Germany). The levels of mtDNA encoding cytochrome c oxidase 1 were measured by quantitative realtime PCR with same volume of the DNA solution. The
following primers were used: mouse cytochrome c oxidaseI forward, 5′-GCCCCAGATATAGCATTCCC-3′,
and reverse, 5′-GTTCATCCTGTTCCTGCTCC-3′.
Electron microscopy (EM)

Electron micrographs of mitochondria in LPS-primed
THP-1 cells were taken after incubation with ATP or
nigericin for 15 min in the presence or the absence
of ethyl pyruvate (5 mM) using HITACHITransmissionElectronMicroscopeH7700
(HITACHI,
Japan).
Objects were magnified 15 thousand times and
macrographs of mitochondria were collected by gatan
ORIUS CCD CAMERA.
Statistical analysis

Data in the figures and text are expressed as mean ± SEM
of at least three independent experiments (n = 3–6).
Significance of difference between groups was determined by two-tailed Students t-test. A p value < 0.05
was considered statistically significant.
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Results
Ethyl pyruvate inhibits NLRP3 agonists-induced
inflammasome activation in mouse macrophages

To determine whether ethyl pyruvate (EP) inhibits the
NLRP3 inflammasome activation, LPS-primed mouse
peritoneal macrophages were stimulated with ATP in
the presence or the absence of different concentrations
of EP. EP exposure dose-dependently inhibited ATPinduced activation of caspase-1, cleavage of pro-IL-1β
and HMGB1 release (Fig. 1a). Addition of EP failed to
inhibit the expression of pro-IL-1β in the cell lysate (Fig.
1a), indicating that the inhibition of IL-1β production by
EP is due to the suppression of inflammasome activation, rather than LPS-induced priming. Further, we observed that EP dose-dependently inhibited ATP-induced
pyroptosis in LPS-primed mouse peritoneal macrophages, as showed by LDH assay (Fig. 1b).
To test whether EP inhibits the NLRP3 inflammasome
activation induced by NLRP3 agonists other than ATP,
LPS-primed mouse peritoneal macrophages were stimulated with nigericin, a known potassium ionophore in the
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presence of absence of different concentrations of
EP. Notably, EP exposure significantly inhibited IL-1β
expression at the concentration of 5 mM. EP slightly
inhibited TNF at the concentration of 5 mM, suggesting that EP more specifically inhibits NLRP3dependent cytokine release (Fig. 1c). Furthermore, EP
dose-dependently inhibits IL-1β production and pyroptosis in LPS-primed mouse peritoneal macrophages
induced by silica and Alum crystal (Fig. 1d). Intriguingly, EP showed weaker inhibitory effect in
crystals-induced NLRP3 inflammasome activation
than that induced by ATP or NIG. Taken together,
these results indicate that EP inhibits the NLRP3
inflammasome activation in mouse macrophages.
Ethyl pyruvate specifically inhibits the NLRP3
inflammasome activation

To address the specificity of EP in inhibiting the NLRP3
inflammasome activation, we next investigated whether
EP inhibits the activation of AIM2 or NLRC4 inflammasome. Mouse peritoneal macrophages were either primed

Fig. 1 Ethyl pyruvate inhibits NLRP3 agonists-induced inflammasome activation in mouse macrophages. a Peritoneal mouse macrophages were
primed with ultra-pure LPS (1 μg/ml) for 3 h. in the presence or the absence of EP (1 or 5 mM), and then stimulated with ATP (5 mM) for 30 min.
The pro-caspase1, cleavage of caspase-1 and Pro-IL-1β, IL-1β and the release of HMGB1 in supernatants and expression of pro-caspase1, pro-IL-1β
in cell were assessed by Western-blot. b Peritoneal mouse macrophages were primed with ultra-pure LPS (1 μg/ml) for 3 h. in the presence or
the absence of EP (1 or 5 mM), and then stimulated with ATP (5 mM) for 30 min. Cytotoxicity was assessed by lactate dehydrogenase (LDH) assay.
c Peritoneal mouse macrophages were primed with ultra-pure LPS (1 μg/ml) for 3 h. in the presence or the absence of EP (1 or 5 mM), and then
stimulated with ATP (5 mM) or nigericin (10 μM) for 30 min. Levels of IL-1β and TNF-α in the culture medium were determined by ELISA. d Peritoneal
mouse macrophages were primed with ultra-pure LPS (1 μg/ml) for 3 h. with or without EP (5 or 10 mM), and then stimulated with alum (20 μg/ml)
or silica (10 μg/ml) 6h. Cytotoxicity was analyzed by LDH assay and IL-1β level was determined by ELISA. Results are means ± SEM (n = 3). *p < 0.05;
**p < 0.01; ***p < 0.001
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with LPS and then stimulated with nigericin, or directly
stimulated with salmonella typhimurium (ST), a known
NLRC4 inflammasome agonist (Mariathasan et al., 2004),
or transfected with poly(dA-dT). poly(dA-dT) (hereafter
termed poly (dA: dT)), a known AIM2 inflammasome
agonist (Hornung et al., 2009; Fernandes-Alnemri et al.,
2009). Consistently, EP exposure dose-dependently inhibited HMGB1 release in nigericin-treated macrophages.
However, the addition of EP failed to inhibit caspase-1 activation and HMGB1 release induced by salmonella typhimurium infection or poly(dA:dT) transfection (Fig. 2a-b).
These results indicate that EP specifically inhibits the
NLRP3 inflammasome activation.
Inhibition of NLRP3 activation by EP is independent of
potassium efflux

A role of potassium (K+) efflux in NLRP3 activation has
been proposed since several NLRP3 activators including
ATP, NIG, MSU and particulate matters like silica and
Alum crystal trigger the efflux of K+ and preventing K+ efflux blocks inflammasome activation induced by NLRP3
agonists (Muñoz-Planillo et al., 2013; He et al., 2016).
Therefore, we next determined whether EP inhibits the
NLRP3 inflammasome activation through regulating the K
+
efflux. To test this possibility, LPS-primed mouse peritoneal macrophages were stimulated with ATP or nigericin
in the presence or the absence of different concentrations
of EP. EP exposure dose-dependently inhibited ATP- or
NIG-induced cytotoxicity (%) (Fig. 3b) and IL-1β release
(Fig. 3c) whereas failed to affect K+ efflux (Fig. 3a). Thus,
Inhibition of NLRP3 activation by EP is independent of
potassium efflux.
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Inhibition of NLRP3 activation by EP is independent of
lysosomal rupture

It has been proposed that lysosomal rupture mediates
the NLRP3 inflammasome activation induced by particulate matters, such as silica and Alum crystal (Hornung
et al., 2008; Halle et al., 2008). Since EP inhibits the
NLRP3 inflammasome activation induced by particulate
matters including silica and alum crystal, we investigated
whether EP inhibits the NLRP3 inflammasome activation through regulating the lysosomal rupture. To test
this possibility, LPS-primed mouse peritoneal macrophages were stimulated with silica or Alum crystal in the
presence or the absence of different concentrations of
EP, and lysosomal rupture was assessed by flow cytometry. Surprisingly, EP exposure failed to prevent, but instead
promoted silica- or Alum-induced lysosomal rupture
(Fig. 4a), although EP dose-dependently inhibited
silica- or Alum-induced cytotoxicity (Fig. 4b). Therefore, inhibition of NLRP3 activation by EP is independent of lysosomal rupture.
Ethyl pyruvate inhibits NLRP3 agonists-induced
mitochondrial damage

In addition to K+ efflux and lysosomal rupture, accumulated evidence show that mitochondrial damage is critical for the NLRP3 inflammasome activation (Zhou
et al., 2011; Nakahira et al., 2011; Shimada et al., 2012;
Zhong et al., 2016). To test whether ethyl pyruvate prevents NLRP3 agonists-triggered mitochondrial damage,
we directly assessed mitochondrial integrity in human
acute monocytic leukemia cell lines (THP-1) using electron microscopy (EM). Whereas nigericin, and to a

Fig. 2 Ethyl pyruvate specifically inhibits the NLRP3 inflammasome activation. For Salmonella infection, unprimed macrophages were infected
with wild-type S. typhimurium and the supernatant samples were collected 1 h after infection. For the AIM2 inflammasome activation,
macrophages were transfected with DNA using Lipofectamine 2000 and the supernatant samples were collected 6 h after transfection.
a Pro-caspase1, caspase1 and HMGB1 release were assessed by Western-blot. b Supernatant levels of HMGB1were determined by ELISA.
Results are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001
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green fluorecence increased when mitochondrial damage
occurs. EP could reduce the proportion of mitochondrial
damaged cells (Fig. 5c), in accordance with the results by
electron microscopy.
Early studies indicate that mitochondrial DNA
(mtDNA) release into the cytoplasm is highly linked to
the NLRP3 inflammasome activation. Oxidized mtDNA
was reported to function as a direct NLRP3 ligand that
induces the assembly and activation of the NLRP3
inflammasome (Shimada et al., 2012). Accordingly, we
reasoned that EP might prevent mtDNA release into the
cytoplasm. To test this hypothesis, mouse macrophages
were stimulated with ATP or nigericin in the presence
or the absence of EP. The cytoplasmic fraction was analyzed for mtDNA levels using qPCR with primers for
cytochrome C oxidase-1 gene. Indeed, EP inhibits ATPor nigericin-induced mtDNA release into the cytoplasm
(Fig. 5d). These results suggest that the mechanisms by
which EP inhibits the NLRP3 inflammasome activation,
are at least in part, through the inhibition of mitochondrial damage.

Ethyl pyruvate does not inhibit NLRP3 agonists-induced
mtROS production

Fig. 3 Inhibition of NLRP3 activation by EP is independent of potassium
efflux. Peritoneal mouse macrophages were primed with ultra-pure LPS
(1 μg/ml) for 3 h. with or without the presence of EP (1 or 5 mM), and
then stimulated with ATP (5 mM) or nigericin (10 μM) for 30 min.
a Intracellular K+ concentration was measured. b Cytotoxicity was
assessed by lactate dehydrogenase (LDH) cytotoxicity assay. c
Levels of IL-1β in the culture medium was determined by ELISA.
Results are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001

lesser extent, ATP induced accumulation of many highly
damaged, electron-dense mitochondria, this effect was
strongly inhibited by ethyl pyruvate in the concentration
of 5 mM (Fig. 5a-b). To futher confirm the finding that
EP significantly relieves mitochondrial damage, we
employed JC-1, a dye used to detect the mitochondrial
membrane potentialmeasure and assess mitochondrial
integrity. The JC-1 red fluorecence decreased and JC-1

Early studies indicate that mitochondrial reactive oxygen
species (mtROS) production contributes to mitochondrial damage and the NLRP3 inflammasome activation
(Zhou et al., 2011). Accordingly, we next tested whether
EP inhibits NLRP3 agonists-induced mtROS production
in mouse macrophages. A robust mtROS generation was
detected when treated with ATP while little mtROS was
induced when treated with nigericin. Notably, EP did
not inhibit mtROS production in these cells as measured
by flow cytometry (Fig. 6). Together with the finding
that EP inhibits NLRP3 agonists-induced mitochondrial
damage, these observations suggest that the mechanism
through which EP prevents mitochondrial damage and
the NLRP3 inflammasome activation is independent of
mtROS production.

Ethyl pyruvate inhibits NLRP3 agonists-induced
inflammasome activation in human macrophages

We finally examined whether EP inhibits the NLRP3
inflammasome activation in human macrophages. ATP
stimulation of LPS-primed human macrophages rapidly
induced IL-1β secretion, which was dose-dependently
inhibited by EP (Fig. 7a). In contrast, addition of EP at 1
and 5 mM failed to attenuate LPS-induced production
of non-NLRP3 inflammasome dependent cytokines, such
as IL-6 or TNF production (Fig. 7b). This suggests that
EP inhibits the NLRP3 inflammation activation in both
murine and human macrophages.

Li et al. Molecular Medicine (2018) 24:8
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Fig. 4 Inhibition of NLRP3 activation by EP is independent of lysosomal rupture. Peritoneal mouse macrophages were primed with ultra-pure LPS
(1 μg/ml) for 3 h. in the presence or the absence of 5 mM EP, and then stained with acridine orange (1 μg/ml) for 30 min at 37 °C. Cells were
then stimulated by alum (20 μg/ml) or silica (10 μg/ml) 6h. a After stimulation, cells were analyzed by flow cytometry for lysosomal acridine orange
fluorescence. b Cytotoxicity was assessed using LDH assay. Results are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001

Discussion
Ethyl pyruvate is a small molecule and a food additive
that exerts anti-inflammatory effect. We and others previously show that treatment with ethyl pyruvate is able
to ameliorate systemic inflammation and prevents multiple organ dysfunctions in a number of disorders,
including endotoxemia, bacterial sepsis, acute pancreatitis, alcoholic liver injury, acute respiratory distress
syndrome, acute viral myocarditis and acute kidney injury. However, the underlying mechanisms by which
ethyl pyruvate attenuates systemic inflammation remain
elusive. In this study, we first show that ethyl pyruvate
inhibits NLRP3 agonists-induced inflammasome activation through preventing mitochondrial damage. Interestingly, ethyl pyruvate neither inhibits the activation of
AIM2 or NLRC4 inflammasome nor affects the inflammatory responses that are not related to the inflammasome activity.

The NLRP3 inflammasome is an intracellular protein
complex comprised of NLRP3, ASC and caspase-1. Upon
stimulation by a variety of endogenous or exogenous
danger signals, these inflammasome components rapidly
assemble into the active NLRP3 inflammasome, cumulating in the maturation of IL-1β and IL-18, as well as pyroptosis, a lytic form of programmed cell death (Strowig
et al., 2012). The NLRP3 inflammasome importantly
orchestrates host innate immune responses to infections
or sterile injuries. Deregulated NLRP3 inflammasome activity, however, contributes to the pathogenesis of a number of human diseases or life-threatening conditions, such
as endotoxemia, sepsis, alcoholic liver injury, colitis and
acute kidney injury. Together with findings in current
study, these observations could explain why ethyl pyruvate
is able to confer protection in various diseases or lifethreatening conditions. It is noteworthy that ethyl pyruvate is well-known to inhibit HMGB1 release from active

Li et al. Molecular Medicine (2018) 24:8
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Fig. 5 Ethyl pyruvate inhibits NLRP3 agonists-induced mitochondrial damage. a Electron micrographs of mitochondria in LPS-primed THP-1 cells
after incubation with ATP (5 mM) or nigericin (10 μM) for 15 min in the presence or the absence of ethyl pyruvate (5 mM). Shown in panel A are
representative images of normal, partially damaged, or heavily damaged mitochondria. Scale bars, 1 um. b Quantification of damaged mitochondria in
(a). Results are means ± SEM (n = 6). c Mouse macrophages were primed with LPS or LPS + EP, followed by treatment with ATP (5 mM, 20 min). Cells
were stained with JC-1 and analyzed by a flow cytometer. Cells in the gate represent mitochondrial depolarization or mitochondrial damage. d mtDNA
release from LPS-primed mouse peritoneal macrophages after stimulation of ATP (5 mM) or nigericin (10 μM) for 30 min in the presence
or the absence of ethyl pyruvate (5 mM). Results are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001

immune cells or in inflammatory diseases (Ulloa et al.,
2002; Miyaji et al., 2003; Davé et al., 2009). HMGB1 is a
proinflammatory mediator that contributes to the pathogenesis of many disorders, including sepsis and colitis. We
and others recently found that the release of HMGB1 is an
important downstream event of inflammasome activation
(Nakahira et al., 2011; Groß et al., 2016). Neutralizing
extracellular HMGB1 with monoclonal antibodies confers
considerate protection against Caspase-1/Caspase-11-mediated lethality during endotoxemia (Lamkanfi et al., 2010).
Consistent with these findings, we observed in this study
that ethyl pyruvate dose-dependently inhibits the NLRP3
agonists-induced HMGB1 release.
Though the NLRP3 inflammasome has been extensively studied due to its important roles in immune
responses and diseases, how various endogenous or exogenous danger signals activate the NLRP3 inflammasome still remains largely unknown. In recent years,
several cellular events have been proposed to be the

triggers for the NLRP3 inflammasome activation. These
include potassium efflux, lysosomal rupture, mitochondrial reactive oxygen species (ROS) production and
mitochondrial damage. Potassium efflux could be induced by most NLRP3 stimuli, and therefore has been
proposed to be the common pathway for the NLRP3
inflammasome activation. However, ethyl pyruvate has no
detectable effect on the ATP- or nigericin-induced potassium efflux at the concentration, when it could completely
abolish ATP- or nigericin-induced inflammasome activation.
These observations suggest that ethyl pyruvate inhibits the
NLRP3 inflammasome activation through affecting the
downstream signal of potassium efflux. Disruption of the
lysosomal membrane, caused by phagocytosis of particulate
matter such as silica or Alum crystals, could also activate
the NLRP3 inflammasome. Though ethyl pyruvate could effectively inhibit silica- or Alum-induced inflammasome activation, it barely affects the phagosomal rupture-induced by
silica- or Alum. Further, we also noticed that ethyl pyruvate
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Fig. 6 Ethyl pyruvate does not inhibit NLRP3 agonists-induced mtROS production. MtROS levels were determined by MitoSOX staining of LPS-primed
human acute monocytic leukemia cell lines (THP-1) after stimulation with ATP (5 mM) or nigericin (10 μM) in the presence or the absence of 5 mM EP

fails to inhibit ATP-induced mitochondrial ROS production.
A number of studies demonstrate that mitochondrial ROS
is critical for the NLRP3 inflammasome activation (Zhou
et al., 2011; Nakahira et al., 2011; Groß et al., 2016). However, some other studies indicate that mitochondrial ROS is
dispensable for the activation of NLRP3 inflammasome
(Muñoz-Planillo et al., 2013; Bauernfeind et al., 2011; Won

et al., 2013). One explanation for the discrepancy is that
mitochondrial ROS activate the NLRP3 inflammasome in
the context-dependent manner, which suggests that the
downstream events of mitochondrial ROS might be the actual trigger for the NLRP3 inflammasome activation.
Excessive mitochondrial ROS could lead to mitochondrial damage. Accumulated evidences show an essential

Fig. 7 Ethyl pyruvate inhibits NLRP3 agonists-induced inflammasome activation in human macrophages. Human macrophages were primed with
ultra-pure LPS (1 μg/ml) for 3 h. in the presence or the absence of EP (1 or 5 mM), and then stimulated with ATP (5 mM) for 30 min. a IL-1β level
and (b) IL-6, TNF production were determined by ELISA. Results are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001
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role of mitochondrial damage in the NLRP3 inflammasome activation (Zhong et al., 2016; Wang et al., 2014;
Shimada et al., 2012; Iyer et al., 2013). Iyer et al. show
that the cytosolic oxidized mitochondrial DNA released
by damaged mitochondria serve as NLRP3 ligands and
could induce the NLRP3 inflammasome activation
(Shimada et al., 2012). Another study demonstrates that
the cardiolipins exposed on the surface of damaged
mitochondria can directly bind NLRP3 and play critical roles in the activation of NLRP3 inflammasome
(Iyer et al., 2013). As show in current study, ethyl pyruvate
prevents mitochondrial damage and inhibits the release of
mitochondrial DNA into the cytosol in NLRP3 agoniststimulated macrophages. Though whether cytosolic oxidized mitochondrial DNA is a bona fide NLRP3 ligand
requires further investigation, our findings suggest
that ethyl pyruvate inhibits the NLRP3 inflammasome
activation, at least in part, through preventing mitochondrial damage.

Conclusion
Together, our findings establish ethyl pyruvate as a
novel NLRP3 inhibitor and unravel the mechanisms
by which this metabolite derivative exerts antiinflammatory effect in various types of diseases or illnesses, such as sepsis, alcoholic liver injury, and acute
kidney injury. Mechanistically, ethyl pyruvate inhibits
the NLRP3 inflammasome activation, at least in part,
by reducing mitochondrial damage.
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